
|Articles|April 2, 2013
Opportunities and Challenges in Developing Stem Cell Therapies
A conversation with Armand Keating, the Epstein Chair in Cell Therapy and Transplantation at the University of Toronto prior to his presentation at Bio 2013
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Biopharma Navigates the 2026 Economic Shift
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
5




